106 related articles for article (PubMed ID: 7715039)
1. Plasma concentration of lipoprotein(a) and the risk of future stroke.
Ridker PM; Stampfer MJ; Hennekens CH
JAMA; 1995 Apr; 273(16):1269-73. PubMed ID: 7715039
[TBL] [Abstract][Full Text] [Related]
2. A prospective study of lipoprotein(a) and the risk of myocardial infarction.
Ridker PM; Hennekens CH; Stampfer MJ
JAMA; 1993 Nov; 270(18):2195-9. PubMed ID: 8411602
[TBL] [Abstract][Full Text] [Related]
3. Lipoprotein (a), lipids, aspirin, and risk of myocardial infarction in the Physician's Health Study.
Ariyo A; Hennekens CH; Stampfer MJ; Ridker PM
J Cardiovasc Risk; 1998 Aug; 5(4):273-8. PubMed ID: 9919476
[TBL] [Abstract][Full Text] [Related]
4. Lipoprotein(a) levels and risk of coronary heart disease in men. The lipid Research Clinics Coronary Primary Prevention Trial.
Schaefer EJ; Lamon-Fava S; Jenner JL; McNamara JR; Ordovas JM; Davis CE; Abolafia JM; Lippel K; Levy RI
JAMA; 1994 Apr; 271(13):999-1003. PubMed ID: 8139085
[TBL] [Abstract][Full Text] [Related]
5. Prospective study of endogenous tissue plasminogen activator and risk of stroke.
Ridker PM; Hennekens CH; Stampfer MJ; Manson JE; Vaughan DE
Lancet; 1994 Apr; 343(8903):940-3. PubMed ID: 7909008
[TBL] [Abstract][Full Text] [Related]
6. Lipoprotein(a), measured with an assay independent of apolipoprotein(a) isoform size, and risk of future cardiovascular events among initially healthy women.
Suk Danik J; Rifai N; Buring JE; Ridker PM
JAMA; 2006 Sep; 296(11):1363-70. PubMed ID: 16985228
[TBL] [Abstract][Full Text] [Related]
7. Relationship between lipoprotein (a) and both stroke and carotid atheroma.
Markus HS; Kapadia R; Sherwood RA
Ann Clin Biochem; 1997 Jul; 34 ( Pt 4)():360-5. PubMed ID: 9247666
[TBL] [Abstract][Full Text] [Related]
8. Lipoprotein(a) and other risk factors for cerebral infarction.
Konemori G
Hiroshima J Med Sci; 1995 Sep; 44(3):65-77. PubMed ID: 8567315
[TBL] [Abstract][Full Text] [Related]
9. A prospective study of plasma homocyst(e)ine and risk of ischemic stroke.
Verhoef P; Hennekens CH; Malinow MR; Kok FJ; Willett WC; Stampfer MJ
Stroke; 1994 Oct; 25(10):1924-30. PubMed ID: 8091435
[TBL] [Abstract][Full Text] [Related]
10. Plasma lipoprotein(a) concentration predicts future coronary and cardiovascular events in patients with stable coronary heart disease.
Nestel PJ; Barnes EH; Tonkin AM; Simes J; Fournier M; White HD; Colquhoun DM; Blankenberg S; Sullivan DR
Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2902-8. PubMed ID: 24092750
[TBL] [Abstract][Full Text] [Related]
11. A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction.
Stampfer MJ; Krauss RM; Ma J; Blanche PJ; Holl LG; Sacks FM; Hennekens CH
JAMA; 1996 Sep; 276(11):882-8. PubMed ID: 8782637
[TBL] [Abstract][Full Text] [Related]
12. Lipoprotein(a) in patients with acute cerebral ischemia.
van Kooten F; van Krimpen J; Dippel DW; Hoogerbrugge N; Koudstaal PJ
Stroke; 1996 Jul; 27(7):1231-5. PubMed ID: 8685934
[TBL] [Abstract][Full Text] [Related]
13. Lp(a) lipoprotein, vascular disease, and mortality in the elderly.
Ariyo AA; Thach C; Tracy R;
N Engl J Med; 2003 Nov; 349(22):2108-15. PubMed ID: 14645638
[TBL] [Abstract][Full Text] [Related]
14. Lipoprotein (a) and risk of ischemic stroke in young adults.
Rigal M; Ruidavets JB; Viguier A; Petit R; Perret B; Ferrieres J; Larrue V
J Neurol Sci; 2007 Jan; 252(1):39-44. PubMed ID: 17113602
[TBL] [Abstract][Full Text] [Related]
15. Plasma lipoprotein(a) [Lp(a)] concentrations and cardiovascular events in the elderly: evidence from the prospective study of pravastatin in the elderly at risk (PROSPER).
Gaw A; Murray HM; Brown EA;
Atherosclerosis; 2005 Jun; 180(2):381-8. PubMed ID: 15910866
[TBL] [Abstract][Full Text] [Related]
16. Lipoprotein-a: a laboratory tool for clinical categorization of CVD.
Hoque MM; Sultana P; Arslan MI
Mymensingh Med J; 2005 Jan; 14(1):75-9. PubMed ID: 15695961
[TBL] [Abstract][Full Text] [Related]
17. Relation of serum homocysteine and lipoprotein(a) concentrations to atherosclerotic disease in a prospective Finnish population based study.
Alfthan G; Pekkanen J; Jauhiainen M; Pitkäniemi J; Karvonen M; Tuomilehto J; Salonen JT; Ehnholm C
Atherosclerosis; 1994 Mar; 106(1):9-19. PubMed ID: 8018111
[TBL] [Abstract][Full Text] [Related]
18. Lp(a) lipoprotein and plasminogen activity in patients with different etiology of ischemic stroke.
Petersen NH; Schmied AB; Zeller JA; Plendl H; Deuschl G; Zunker P
Cerebrovasc Dis; 2007; 23(2-3):188-93. PubMed ID: 17143002
[TBL] [Abstract][Full Text] [Related]
19. Lipoprotein(a) as a correlate of stroke and transient ischemic attack prevalence in a biracial cohort: the ARIC Study. Atherosclerosis Risk in Communities.
Schreiner PJ; Chambless LE; Brown SA; Watson RL; Toole J; Heiss G
Ann Epidemiol; 1994 Sep; 4(5):351-9. PubMed ID: 7981841
[TBL] [Abstract][Full Text] [Related]
20. All-cause mortality and competing risks of fatal and nonfatal vascular events in the Italian longitudinal study on aging: impact of lipoprotein(a).
Solfrizzi V; Colacicco AM; D'Introno A; Capurso C; Chirico M; Frisardi V; Cacciapaglia M; Vendemiale G; Capurso A; Panza F
Rejuvenation Res; 2009 Dec; 12(6):395-402. PubMed ID: 20014954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
